PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
HAE vs. SPY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between HAE and SPY is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.4

Performance

HAE vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Haemonetics Corporation (HAE) and SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%SeptemberOctoberNovemberDecember2025February
-17.35%
7.41%
HAE
SPY

Key characteristics

Sharpe Ratio

HAE:

-0.34

SPY:

1.75

Sortino Ratio

HAE:

-0.25

SPY:

2.36

Omega Ratio

HAE:

0.97

SPY:

1.32

Calmar Ratio

HAE:

-0.20

SPY:

2.66

Martin Ratio

HAE:

-0.68

SPY:

11.01

Ulcer Index

HAE:

17.33%

SPY:

2.03%

Daily Std Dev

HAE:

34.58%

SPY:

12.77%

Max Drawdown

HAE:

-68.62%

SPY:

-55.19%

Current Drawdown

HAE:

-54.82%

SPY:

-2.12%

Returns By Period

In the year-to-date period, HAE achieves a -19.29% return, which is significantly lower than SPY's 2.36% return. Over the past 10 years, HAE has underperformed SPY with an annualized return of 3.64%, while SPY has yielded a comparatively higher 12.96% annualized return.


HAE

YTD

-19.29%

1M

-14.08%

6M

-17.35%

1Y

-15.86%

5Y*

-11.86%

10Y*

3.64%

SPY

YTD

2.36%

1M

-1.07%

6M

7.41%

1Y

19.73%

5Y*

14.21%

10Y*

12.96%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

HAE vs. SPY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HAE
The Risk-Adjusted Performance Rank of HAE is 2929
Overall Rank
The Sharpe Ratio Rank of HAE is 2929
Sharpe Ratio Rank
The Sortino Ratio Rank of HAE is 2626
Sortino Ratio Rank
The Omega Ratio Rank of HAE is 2626
Omega Ratio Rank
The Calmar Ratio Rank of HAE is 3434
Calmar Ratio Rank
The Martin Ratio Rank of HAE is 3232
Martin Ratio Rank

SPY
The Risk-Adjusted Performance Rank of SPY is 7676
Overall Rank
The Sharpe Ratio Rank of SPY is 7676
Sharpe Ratio Rank
The Sortino Ratio Rank of SPY is 7272
Sortino Ratio Rank
The Omega Ratio Rank of SPY is 7575
Omega Ratio Rank
The Calmar Ratio Rank of SPY is 7878
Calmar Ratio Rank
The Martin Ratio Rank of SPY is 8080
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

HAE vs. SPY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Haemonetics Corporation (HAE) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for HAE, currently valued at -0.34, compared to the broader market-2.000.002.00-0.341.75
The chart of Sortino ratio for HAE, currently valued at -0.25, compared to the broader market-4.00-2.000.002.004.006.00-0.252.36
The chart of Omega ratio for HAE, currently valued at 0.97, compared to the broader market0.501.001.502.000.971.32
The chart of Calmar ratio for HAE, currently valued at -0.20, compared to the broader market0.002.004.006.00-0.202.66
The chart of Martin ratio for HAE, currently valued at -0.68, compared to the broader market-10.000.0010.0020.0030.00-0.6811.01
HAE
SPY

The current HAE Sharpe Ratio is -0.34, which is lower than the SPY Sharpe Ratio of 1.75. The chart below compares the historical Sharpe Ratios of HAE and SPY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
-0.34
1.75
HAE
SPY

Dividends

HAE vs. SPY - Dividend Comparison

HAE has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.18%.


TTM20242023202220212020201920182017201620152014
HAE
Haemonetics Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SPY
SPDR S&P 500 ETF
1.18%1.21%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%1.87%

Drawdowns

HAE vs. SPY - Drawdown Comparison

The maximum HAE drawdown since its inception was -68.62%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for HAE and SPY. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-54.82%
-2.12%
HAE
SPY

Volatility

HAE vs. SPY - Volatility Comparison

Haemonetics Corporation (HAE) has a higher volatility of 16.69% compared to SPDR S&P 500 ETF (SPY) at 3.38%. This indicates that HAE's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February
16.69%
3.38%
HAE
SPY
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab